Total Payments
$707.85
2024 Payments
$707.85
Companies
11
Transactions
33
Payment Breakdown by Category
Food & Beverage$707.85 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $707.85 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $223.33 | 13 | $0 (2024) |
| GENZYME CORPORATION | $142.59 | 2 | $0 (2024) |
| Amgen Inc. | $76.82 | 3 | $0 (2024) |
| Ardelyx, Inc. | $71.91 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $51.48 | 3 | $0 (2024) |
| Madrigal Pharmaceuticals | $36.85 | 2 | $0 (2024) |
| QOL Medical, LLC | $33.77 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $19.54 | 1 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $17.91 | 1 | $0 (2024) |
| ABBVIE INC. | $17.43 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $707.85 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($223.33) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 10/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.49 | General |
| 10/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $24.65 | General |
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: GENETIC DISEASE | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Gastroenterology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: INTERNAL MEDICINE | ||||||
About Christiane Silver
Christiane Silver is a Family healthcare provider based in Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1861819492.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christiane Silver has received a total of $707.85 in payments from pharmaceutical and medical device companies, with $707.85 received in 2024. These payments were reported across 33 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($707.85).
Ad
Practice Information
- Specialty Family
- Location Ozone Park, NY
- Active Since 03/20/2014
- Last Updated 04/24/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861819492
Products in Payments
- ENTYVIO (Biological) $163.72
- DUPIXENT (Biological) $142.59
- IBSRELA (Drug) $71.91
- RESMETIROM (Drug) $36.85
- XIFAXAN (Drug) $34.14
- SUCRAID (Drug) $33.77
- VPRIV (Biological) $32.78
- HYQVIA (Biological) $26.83
- TREMFYA (Drug) $19.54
- OCALIVA (Drug) $17.91
- RINVOQ (Biological) $17.43
- TRULANCE (Drug) $17.34
- VOQUEZNA (Drug) $16.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.